Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father

Not Applicable

Recruiting

• Conditions: Depression, Postpartum

• Registration Number: NCT06772701
• Lead Sponsor: Groupe Hospitalier du Havre

Brief Summary

In recent years, fatherhood has changed considerably. Fathers are now more involved during the perinatal period, with their partner but also in caring for the child. We now know that this period is also a source of major psychological upheaval, identity crisis, apprehension and anxiety for men. These upheavals can lead to depression that must be detected and treated as early as possible. This is an easy screening to perform using the EPDS (Edinburgh Postnatal Depression Scale). Currently, the EPDS is the most widely used self-questionnaire to assess the risk of depression in women during the perinatal period. Indeed, it is systematically recommended in many countries. It is starting to be used for the same purpose in the perinatal period in men, although the scale has not been validated in a representative sample of men in the pre- or post-natal period.

The main objective is to validate the use of the EPDS scale as a screening tool for postnatal depression in a population of French fathers.

They complete the PH-Q9, EPDS and socio-demographic questionnaires online at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity ward also too Mini International Neuropsychiatric Interview (MINI) at inclusion.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-11
• Status Verified: 2025-01
• Study First Submitted: 2025-01-09
• Study First Submitted QC: 2025-01-09
• Last Update Submitted: 2025-01-09
• Study First Posted: 2025-01-13
• Last Update Posted: 2025-01-13
• Primary Completion: 2025-09-12
• Study Completion: 2025-09-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Male
• Target Recruitment: 1000

Inclusion Criteria

• All fathers whose baby is 10 days old or less

Exclusion Criteria

• People with a poor understanding of spoken or written French
• Minors
• Persons under court protection, guardianship or curatorship

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mini International Neuropsychiatric Interview	at inclusion	This short structured clinical interview is used to diagnose psychiatric disorders and is currently the gold standard for diagnosing depression.

Secondary Outcome Measures

Name	Time	Method
socio-demographic questionnaire	at inclusion and 6 to 8 weeks after the birth of their child	Socio-demographic data will be a secondary evaluation criterion. It will be used to study risk and protective factors, both those already known in the literature and those that have been little studied, and to identify profiles that are more at risk, with a view to taking preventive action in the field.

Trial Locations

Locations (2)

Antoine-Béclère hospital AP-HP; 🇫🇷 Clamart, France

Le Havre hospital - site Jacques Monod; 🇫🇷 Montivilliers, France